Connection

Paolo Maggi to Tenofovir

Back to Details
This is a "connection" page, showing publications Paolo Maggi has written about Tenofovir.
Paolo Maggi
Connection Strength
0.417
Tenofovir
  1. Safety and tolerability of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil fumarate in a real life setting: Data from surveillance cohort long-term toxicity antiretrovirals/antivirals (SCOLTA) project. PLoS One. 2017; 12(6):e0179254.
    View in: PubMed
    Score: 0.129
  2. Co-administration of tenofovir plus protease inhibitor based antiretroviral therapy during sofosbuvir/ledipasvir treatment for HCV infection: Much Ado About Nothing? Clin Res Hepatol Gastroenterol. 2017 10; 41(5):e76-e79.
    View in: PubMed
    Score: 0.128
  3. Long-term efficacy and safety of switching from lamivudine+adefovir to tenofovir disoproxil fumarate in virologically suppressed patients. Dig Liver Dis. 2017 May; 49(5):530-534.
    View in: PubMed
    Score: 0.126
  4. A Comprehensive Development Agenda on Tenofovir Alafenamide in Clinical Practice. AIDS Rev. 2018 Apr-Jun; 20(2):75-82.
    View in: PubMed
    Score: 0.034
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.